Axsome Therapeutics (NASDAQ:AXSM) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $153.00 target price on the stock. Other analysts also recently issued research reports about the stock. Needham & Company LLC increased their target price on […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $153.00 target price on the stock. Other analysts also recently issued research reports about the stock. Needham & Company LLC increased their target price on […]
